NRx Pharmaceuticals to Spotlight Ketamine’s Potential and Risks in Keynote Address at Sachs Neuroscience Innovation Forum
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has announced that it will present a keynote address at the highly anticipated Sachs Neuroscience Innovation Forum in San Francisco later today.
NRx Pharmaceuticals to Spotlight Ketamine’s Potential and Risks in Keynote Address at Sachs Neuroscience Innovation Forum Read More